Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy

Chitalia, Miliotis et al. evaluate radiomic predictors of outcome in patients with breast cancer treated with neoadjuvant chemotherapy. The authors identify radiomic phenotypes related to changes in tumor heterogeneity that improve progression-free survival prediction when added to clinicopathologic...

Full description

Bibliographic Details
Published in:Communications Medicine
Main Authors: Rhea Chitalia, Marios Miliotis, Nariman Jahani, Spyros Tastsoglou, Elizabeth S. McDonald, Vivian Belenky, Eric A. Cohen, David Newitt, Laura J. van’t Veer, Laura Esserman, Nola Hylton, Angela DeMichele, Artemis Hatzigeorgiou, Despina Kontos
Format: Article
Language:English
Published: Nature Portfolio 2023-03-01
Online Access:https://doi.org/10.1038/s43856-023-00273-1